Caused by loss-of-function mutations in the PHEX (phosphate-regulating endopeptidase homolog, X-linked) gene, XLH is characterized by high circulating levels of fibroblast growth factor 23 (FGF23). The gene discussed is FGF23; the disease is X-linked hypophosphatemia.